Clinical Trial Update: SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access

View source ↗

Summary

The SPECTAmel trial, which screened melanoma patients to improve access to clinical trials, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Melanoma | Status: WITHDRAWN